J.-P. Pelletier
Impact in
- Rheumatology top 0.1%
- Osteoarthritis Treatment and Mechanisms
- Rheumatoid Arthritis Research and Therapies
- Equine top 1%
Papers in
- Rheumatology 47
- Osteoarthritis Treatment and Mechanisms 39
- Rheumatoid Arthritis Research and Therapies 17
- Pharmacology 12
- Inflammatory mediators and NSAID effects 12
- Co-authors
- Johanne Martel‐Pelletier (50 shared papers)Wim B. van den Berg (1 shared paper)Keld Østergaard (1 shared paper)Sergio A. Jiménez (1 shared paper)Peter A. Revell (1 shared paper)Steffen Gay (1 shared paper)Donald M. Salter (1 shared paper)Kenneth P. H. Pritzker (1 shared paper)
- Journals
- Osteoarthritis and Cartilage (30 papers)Annals of the Rheumatic Diseases (8 papers)Modern Rheumatology (1 paper)Journal of Orthopaedic Research® (1 paper)IEEE Transactions on Biomedical Engineering (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
J.-P. Pelletier
58 papers receiving 4.1k citations
J.-P. Pelletier's Hit Papers
Peers
Comparison fields: 5 of 122
- Rheumatology 2.7k
- Equine 116
- Pharmacology 701
- Cancer Research 544
- Orthopedics and Sports Medicine 282
Countries citing papers authored by J.-P. Pelletier
This map shows the geographic impact of J.-P. Pelletier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. Pelletier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. Pelletier more than expected).
Fields of papers citing papers by J.-P. Pelletier
This network shows the impact of papers produced by J.-P. Pelletier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. Pelletier. The network helps show where J.-P. Pelletier may publish in the future.
Co-authors
The 25 scholars most cited alongside J.-P. Pelletier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Osteoarthritis cartilage histopathology: grading and staging Hit paper breakdown → | 2005 | 1901 |
| 2 | 1996 | 417 | |
| 3 | Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. | 1994 | 229 |
| 4 | 2010 | 164 | |
| 5 | 2008 | 139 | |
| 6 | 2003 | 112 | |
| 7 | 2008 | 94 | |
| 8 | Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study. | 1998 | 90 |
| 9 | The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis. | 1995 | 86 |
| 10 | In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes. | 1998 | 81 |
| 11 | Diacerhein and rhein reduce the interleukin 1beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes. | 1998 | 80 |
| 12 | 2002 | 78 | |
| 13 | In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage. | 1991 | 68 |
| 14 | Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis. | 2000 | 60 |
| 15 | Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha. | 1997 | 57 |
| 16 | 2002 | 48 | |
| 17 | 1988 | 42 | |
| 18 | Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages. | 2001 | 38 |
| 19 | 2003 | 37 | |
| 20 | 1999 | 36 |
About J.-P. Pelletier
J.-P. Pelletier is a scholar working on Rheumatology, Pharmacology, Cell Biology, Molecular Biology and Oncology, having authored 63 papers that have together received 4.2k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (39 papers), Rheumatoid Arthritis Research and Therapies (17 papers), Inflammatory mediators and NSAID effects (12 papers), Proteoglycans and glycosaminoglycans research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Medicinal plant effects and applications (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Bone and Joint Diseases (3 papers). The work is most often cited by research in Rheumatology (2.7k citations), Equine (116 citations), Pharmacology (701 citations), Cancer Research (544 citations) and Orthopedics and Sports Medicine (282 citations). J.-P. Pelletier has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Johanne Martel‐Pelletier, Wim B. van den Berg, Keld Østergaard, Sergio A. Jiménez, Peter A. Revell, Steffen Gay, Donald M. Salter, Kenneth P. H. Pritzker, J M Cloutier and Ginette Tardif. Their work appears in journals such as Osteoarthritis and Cartilage, Annals of the Rheumatic Diseases, Modern Rheumatology, Journal of Orthopaedic Research® and IEEE Transactions on Biomedical Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.